Paper31377342
Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU and 8 others. J Allergy Clin Immunol, 2019. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy. Papers, record 31377342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31377342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 2S Albumins, Plant | Major topic |
| Antigens, Plant | Major topic |
| Basophil Degranulation Test | Major topic |
| Basophils | Major topic |
| Desensitization, Immunologic | Major topic |
| Peanut Hypersensitivity | Major topic |
| Administration, Oral | |
| Adolescent | |
| Arachis | |
| Child | |
| Female | |
| Humans | |
| Immunoglobulin E | |
| Male | |
| Prognosis | |
| Treatment Outcome |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| L40 AI120059 | NIAID NIH HHS | United States | L40AI120059 | PubMed and NIH | NIH RePORTER |
| S10 RR020936 | NCRR NIH HHS | United States | S10RR020936 | PubMed | NIH RePORTER |
| S10 OD012027 | NIH HHS | United States | S10OD012027 | PubMed | NIH RePORTER |
| K23 AI121491 | NIAID NIH HHS | United States | K23AI121491 | PubMed and NIH | NIH RePORTER |
| S10 RR023440 | NCRR NIH HHS | United States | S10RR023440 | PubMed | NIH RePORTER |
| K23 AI130408 | NIAID NIH HHS | United States | K23AI130408 | PubMed | NIH RePORTER |
| UL1 TR000170 | NCATS NIH HHS | United States | UL1TR000170 | PubMed | NIH RePORTER |
| UL1 TR001102 | NCATS NIH HHS | United States | UL1TR001102 | PubMed | NIH RePORTER |
| UL1 RR025758 | NCRR NIH HHS | United States | UL1RR025758 | PubMed | NIH RePORTER |
| S10 OD016372 | NIH HHS | United States | S10OD016372 | PubMed | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 31589878 | Blocking antibodies in immunotherapy: Quality versus quantity. | https://conductscience.org/library/papers/31589878 |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25670011 | IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. | J Allergy Clin Immunol | 2015 | https://conductscience.org/library/papers/25670011 | PubMed |
| 2 | 27015954 | Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness. | Allergy | 2016 | https://conductscience.org/library/papers/27015954 | PubMed |
| 3 | 22385632 | Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. | J Allergy Clin Immunol | 2012 | https://conductscience.org/library/papers/22385632 | PubMed |
| 4 | 22702505 | Subthreshold desensitization of human basophils re-capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization. | Clin Exp Allergy | 2012 | https://conductscience.org/library/papers/22702505 | PubMed |
| 5 | 21377034 | A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. | J Allergy Clin Immunol | 2011 | https://conductscience.org/library/papers/21377034 | PubMed |
| 6 | 28618090 | Road map for the clinical application of the basophil activation test in food allergy. | Clin Exp Allergy | 2017 | https://conductscience.org/library/papers/28618090 | PubMed |
| 7 | 18572230 | Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. | J Allergy Clin Immunol | 2008 | https://conductscience.org/library/papers/18572230 | PubMed |
| 8 | 25567046 | Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. | J Allergy Clin Immunol | 2015 | https://conductscience.org/library/papers/25567046 | PubMed |
| 9 | 20462634 | US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. | J Allergy Clin Immunol | 2010 | https://conductscience.org/library/papers/20462634 | PubMed |
| 10 | 22132885 | Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation. | Clin Exp Immunol | 2012 | https://conductscience.org/library/papers/22132885 | PubMed |
| 11 | 21281959 | Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. | J Allergy Clin Immunol | 2011 | https://conductscience.org/library/papers/21281959 | PubMed |
| 12 | 22077562 | Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. | Allergy | 2012 | https://conductscience.org/library/papers/22077562 | PubMed |
| 13 | 22805467 | Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. | Clin Exp Allergy | 2012 | https://conductscience.org/library/papers/22805467 | PubMed |
| 14 | 25042981 | Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/25042981 | PubMed |
| 15 | 26774660 | Parameters determining the efficacy of CD32 to inhibit activation of FcεRI in human basophils. | J Allergy Clin Immunol | 2016 | https://conductscience.org/library/papers/26774660 | PubMed |
| 16 | 25065721 | Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/25065721 | PubMed |
| 17 | 16096348 | ROCR: visualizing classifier performance in R. | Bioinformatics | 2005 | https://conductscience.org/library/papers/16096348 | PubMed |
| 18 | 26198455 | The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. | Allergy | 2015 | https://conductscience.org/library/papers/26198455 | PubMed |
| 19 | 29288078 | Immune mechanisms of oral immunotherapy. | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/29288078 | PubMed |
| 20 | 25542883 | Suppression of the immunologic response to peanut during immunotherapy is often transient. | J Allergy Clin Immunol | 2015 | https://conductscience.org/library/papers/25542883 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42094701 | Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42094701 | PubMed |
| 41913645 | Predictive Biomarkers for Sustained Unresponsiveness Following Oral Immunotherapy. | Clin Exp Allergy | 2026 | https://conductscience.org/library/papers/41913645 | PubMed |
| 41660622 | Emerging diagnostic and therapeutic opportunities in food allergy. | Front Immunol | 2025 | https://conductscience.org/library/papers/41660622 | PubMed |
| 41225120 | Modulating the Allergen-Specific Immune Response to Achieve Remission of Food Allergy Through Oral Immunotherapy. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41225120 | PubMed |
| 40558527 | Advances in Food Allergy Immunotherapy: Current Strategies and Role of Antibodies Isotypes. | Cells | 2025 | https://conductscience.org/library/papers/40558527 | PubMed |
| 40542457 | Epitope-Specific Antibodies in Allergic Disease and Clinical Tolerance. | Immunol Rev | 2025 | https://conductscience.org/library/papers/40542457 | PubMed |
| 40498852 | Germline-encoded recognition of peanut underlies development of convergent antibodies in humans. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/40498852 | PubMed |
| 40245952 | Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy. | J Allergy Clin Immunol | 2025 | https://conductscience.org/library/papers/40245952 | PubMed |
| 40154576 | Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop. | J Allergy Clin Immunol | 2025 | https://conductscience.org/library/papers/40154576 | PubMed |
| 39530396 | Immunomodulatory metabolites in IgE-mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling. | Pediatr Allergy Immunol | 2024 | https://conductscience.org/library/papers/39530396 | PubMed |
| 39041740 | Whence and wherefore IgE? | Immunol Rev | 2024 | https://conductscience.org/library/papers/39041740 | PubMed |
| 38460677 | Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy. | J Allergy Clin Immunol | 2024 | https://conductscience.org/library/papers/38460677 | PubMed |
| 38441821 | A Review of Shared Decision-Making, Published Protocols, and Post-desensitization Strategies in Oral Immunotherapy (OIT). | Curr Allergy Asthma Rep | 2024 | https://conductscience.org/library/papers/38441821 | PubMed |
| 38256382 | Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38256382 | PubMed |
| 38140391 | Peanut Allergy and Component-Resolved Diagnostics Possibilities-What Are the Benefits? | Nutrients | 2023 | https://conductscience.org/library/papers/38140391 | PubMed |
| 37849958 | Immune signatures predicting the clinical outcome of peanut oral immunotherapy: where we stand. | Front Allergy | 2023 | https://conductscience.org/library/papers/37849958 | PubMed |
| 37711220 | JAK1 inhibition with abrocitinib decreases allergen-specific basophil and T-cell activation in pediatric peanut allergy. | J Allergy Clin Immunol Glob | 2023 | https://conductscience.org/library/papers/37711220 | PubMed |
| 37350169 | Practical issues of oral immunotherapy for egg or milk allergy. | Clin Exp Pediatr | 2024 | https://conductscience.org/library/papers/37350169 | PubMed |
| 37241015 | Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. | J Pers Med | 2023 | https://conductscience.org/library/papers/37241015 | PubMed |
| 36880703 | Targeting type 2 immunity and the future of food allergy treatment. | J Exp Med | 2023 | https://conductscience.org/library/papers/36880703 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCR3 | 1232 | PubTator's text mining | https://conductscience.org/library/genes/1232 | NCBI Gene |
| CD63 | 967 | PubTator's text mining | https://conductscience.org/library/genes/967 | NCBI Gene |
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31377342
GET https://conductscience.org/api/papers/v1/31377342/references?page=2